<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK531509" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK531509/" /><meta name="ncbi_pagename" content="NKX6-2-Related Disorder - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>NKX6-2-Related Disorder - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="NKX6-2-Related Disorder" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/10/04" /><meta name="citation_author" content="Viorica Chelban" /><meta name="citation_author" content="Namik Kaya" /><meta name="citation_author" content="Fowzan Alkuraya" /><meta name="citation_author" content="Henry Houlden" /><meta name="citation_pmid" content="30285346" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK531509/" /><meta name="citation_keywords" content="NKX6-2-Related Spastic Ataxia with Hypomyelination" /><meta name="citation_keywords" content="SPAX8" /><meta name="citation_keywords" content="SPAX8" /><meta name="citation_keywords" content="NKX6-2-Related Spastic Ataxia with Hypomyelination" /><meta name="citation_keywords" content="Homeobox protein Nkx-6.2" /><meta name="citation_keywords" content="NKX6-2" /><meta name="citation_keywords" content="NKX6-2-Related Disorder" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="NKX6-2-Related Disorder" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Viorica Chelban" /><meta name="DC.Contributor" content="Namik Kaya" /><meta name="DC.Contributor" content="Fowzan Alkuraya" /><meta name="DC.Contributor" content="Henry Houlden" /><meta name="DC.Date" content="2018/10/04" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK531509/" /><meta name="description" content="NKX6-2-related disorder is characterized by a spectrum of progressive neurologic manifestations resulting from diffuse central nervous system hypomyelination. At the severe end of the spectrum is neonatal-onset nystagmus, severe spastic tetraplegia with joint contractures and scoliosis, and visual and hearing impairment, all of which rapidly progress resulting in death in early childhood. At the milder end of the spectrum is normal achievement of early motor milestones in the first year of life followed by slowly progressive complex spastic ataxia with pyramidal findings (spasticity with increased muscle tone and difficulty with gait and fine motor coordination) and cerebellar findings (nystagmus, extraocular movement disorder, dysarthria, titubation, and ataxia) with loss of developmental milestones. To date NKX6-2-related disorder has been reported in 25 individuals from 13 families." /><meta name="og:title" content="NKX6-2-Related Disorder" /><meta name="og:type" content="book" /><meta name="og:description" content="NKX6-2-related disorder is characterized by a spectrum of progressive neurologic manifestations resulting from diffuse central nervous system hypomyelination. At the severe end of the spectrum is neonatal-onset nystagmus, severe spastic tetraplegia with joint contractures and scoliosis, and visual and hearing impairment, all of which rapidly progress resulting in death in early childhood. At the milder end of the spectrum is normal achievement of early motor milestones in the first year of life followed by slowly progressive complex spastic ataxia with pyramidal findings (spasticity with increased muscle tone and difficulty with gait and fine motor coordination) and cerebellar findings (nystagmus, extraocular movement disorder, dysarthria, titubation, and ataxia) with loss of developmental milestones. To date NKX6-2-related disorder has been reported in 25 individuals from 13 families." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK531509/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/nkx6-2-spax/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK531509/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D3324E040F36100000000026100DD.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK531509_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK531509_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/nkx2-1-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ahc/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK531509_"><span class="title" itemprop="name"><i>NKX6-2</i>-Related Disorder</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: <i>NKX6-2</i>-Related Spastic Ataxia with Hypomyelination, SPAX8</div><p class="contrib-group"><span itemprop="author">Viorica Chelban</span>, MD, <span itemprop="author">Namik Kaya</span>, PhD, <span itemprop="author">Fowzan Alkuraya</span>, MD, and <span itemprop="author">Henry Houlden</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK531509_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK531509_ai__"><div class="contrib half_rhythm"><span itemprop="author">Viorica Chelban</span>, MD<div class="affiliation small">Molecular Neuroscience Department<br />University College London Institute of Neurology<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@nablehc.v" class="oemail">ku.ca.lcu@nablehc.v</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Namik Kaya</span>, PhD<div class="affiliation small">Department of Genetics<br />King Faisal Specialist Hospital and Research Centre<br />Riyadh, Saudi Arabia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="as.ude.crhsfk@ayakn" class="oemail">as.ude.crhsfk@ayakn</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Fowzan Alkuraya</span>, MD<div class="affiliation small">Department of Genetics<br />King Faisal Specialist Hospital and Research Centre<br />Riyadh, Saudi Arabia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="as.ude.crhsfk@ayaruklaf" class="oemail">as.ude.crhsfk@ayaruklaf</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Henry Houlden</span>, MD, PhD<div class="affiliation small">Molecular Neuroscience Department<br />University College London Institute of Neurology<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@nedluoh.h" class="oemail">ku.ca.lcu@nedluoh.h</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 4, 2018</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="nkx6-2-spax.Summary" itemprop="description"><h2 id="_nkx6-2-spax_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>NKX6-2</i>-related disorder is characterized by a spectrum of progressive neurologic manifestations resulting from diffuse central nervous system hypomyelination. At the severe end of the spectrum is neonatal-onset nystagmus, severe spastic tetraplegia with joint contractures and scoliosis, and visual and hearing impairment, all of which rapidly progress resulting in death in early childhood. At the milder end of the spectrum is normal achievement of early motor milestones in the first year of life followed by slowly progressive complex spastic ataxia with pyramidal findings (spasticity with increased muscle tone and difficulty with gait and fine motor coordination) and cerebellar findings (nystagmus, extraocular movement disorder, dysarthria, titubation, and ataxia) with loss of developmental milestones. To date <i>NKX6-2</i>-related disorder has been reported in 25 individuals from 13 families.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>NKX6-2</i>-related disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical and neuroimaging findings and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>NKX6</i>-2 identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment is symptomatic and typically involves a multidisciplinary team of specialists in the areas of developmental pediatrics, neurology, pediatric rehabilitation, orthopedics, PT/OT, social work, nutrition, pulmonary/sleep medicine, ophthalmology, audiology, and palliative care.</p><p><i>Surveillance:</i> Sleep studies for evidence of apnea. Routine assessment of: nutritional status and safety of oral intake; development; progression of spasticity and contractures.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>NKX6</i>-2-related disorder is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Once the <i>NKX6</i>-2 pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives, prenatal testing for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="nkx6-2-spax.Diagnosis"><h2 id="_nkx6-2-spax_Diagnosis_">Diagnosis</h2><div id="nkx6-2-spax.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>NKX6-2</i>-related disorder <b>should be suspected</b> in individuals with the following clinical and brain MRI findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Onset between birth and age five years of either spasticity or hypotonia with rapid progression to spasticity (typically manifesting as spastic quadriplegia in those with early onset)</div></li><li class="half_rhythm"><div>Motor delay or developmental delay in those with a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></div></li><li class="half_rhythm"><div>Nystagmus</div></li><li class="half_rhythm"><div>Visual impairment manifest in severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children as loss of visual fixation and ocular pursuit and in older individuals as severe limitation of eye movements</div></li><li class="half_rhythm"><div>Hearing impairment</div></li><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Dystonia particularly involving the upper limbs</div></li></ul><p><b>Brain MRI findings</b></p><ul><li class="half_rhythm"><div><b>Neonatal/childhood-onset disease.</b> Diffuse and severe hypomyelination of subcortical and deep white matter including the external capsules; globi pallidi; thalami; and peridentate, mesencephalon, pons, and cerebellum as early as age nine months. T<sub>2</sub>-weighted and FLAIR signal are diffusely increased in the white matter with corresponding iso- to hyperintense signal on T<sub>1</sub>-weighted images (see <a class="figpopup" href="/books/NBK531509/figure/nkx6-2-spax.F1/?report=objectonly" target="object" rid-figpopup="fignkx62spaxF1" rid-ob="figobnkx62spaxF1">Figure 1</a>).</div></li><li class="half_rhythm"><div><b>Later-onset disease.</b> The same findings as in neonatal/childhood-onset disease plus cerebellar atrophy and diffuse spinal cord volume loss with abnormal T<sub>2</sub>-weighted hyperintensity of the ventral and dorsal horn cells</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="fignkx62spaxF1" co-legend-rid="figlgndnkx62spaxF1"><a href="/books/NBK531509/figure/nkx6-2-spax.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="fignkx62spaxF1" rid-ob="figobnkx62spaxF1"><img class="small-thumb" src="/books/NBK531509/bin/nkx6-2-spax-Image001.gif" src-large="/books/NBK531509/bin/nkx6-2-spax-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndnkx62spaxF1"><h4 id="nkx6-2-spax.F1"><a href="/books/NBK531509/figure/nkx6-2-spax.F1/?report=objectonly" target="object" rid-ob="figobnkx62spaxF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">T<sub>1</sub>-weighted and T<sub>2</sub>-weighted MRIs in <i>NKX6-2</i>-related disorder Column 1. Normal to hyperintense T<sub>1</sub>-weighted white matter signal suggestive of hypomyelination observed in areas corresponding to the T<sub>2</sub>-weighted hyperintense signal change (column 2) involving <a href="/books/NBK531509/figure/nkx6-2-spax.F1/?report=objectonly" target="object" rid-ob="figobnkx62spaxF1">(more...)</a></p></div></div></div><div id="nkx6-2-spax.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>NKX6-2</i>-related disorder <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical and neuroimaging findings and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>NKX6</i>-<i>2</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK531509/table/nkx6-2-spax.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="fignkx62spaxTmoleculargenetictesting" rid-ob="figobnkx62spaxTmoleculargenetictesting">Table 1</a>).</p><p>Molecular genetic testing approaches can include <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) or <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Children with the distinctive findings described in <a href="#nkx6-2-spax.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (<a href="#nkx6-2-spax.Option_1">Option 1</a>), whereas those with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> indistinguishable from many other inherited disorders with ataxia and/or spasticity are more likely to be diagnosed using genomic testing (<a href="#nkx6-2-spax.Option_2">Option 2</a>).</p><div id="nkx6-2-spax.Option_1"><h4>Option 1</h4><p>When the phenotypic and imaging findings suggest the diagnosis of <i>NKX6-2</i>-related disorder, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> is recommended.</p><p><b>An ataxia, spastic paraparesis, or hypomyelinating leukodystrophy <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>NKX6</i>-<i>2</i> and other genes of interest (see <a href="#nkx6-2-spax.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. Of note, given the rarity of <i>NKX6</i>-<i>2</i>-related spastic ataxia with hypomyelination, some panels for ataxia and/or spasticity may not include this gene. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="nkx6-2-spax.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by ataxia and/or spasticity with hypomyelination on brain MRI, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="nkx6-2-spax.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>NKX6</i>-<i>2</i>-Related Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK531509/table/nkx6-2-spax.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nkx6-2-spax.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_nkx6-2-spax.T.molecular_genetic_testing_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_nkx6-2-spax.T.molecular_genetic_testing_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_nkx6-2-spax.T.molecular_genetic_testing_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_nkx6-2-spax.T.molecular_genetic_testing_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>NKX6</i>-<i>2</i></td><td headers="hd_h_nkx6-2-spax.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_nkx6-2-spax.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13/13 families&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_nkx6-2-spax.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown (no data available)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="nkx6-2-spax.TF.1.1"><p class="no_margin">See <a href="/books/NBK531509/#nkx6-2-spax.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="nkx6-2-spax.TF.1.2"><p class="no_margin">See <a href="#nkx6-2-spax.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="nkx6-2-spax.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="nkx6-2-spax.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#nkx6-2-spax.REF.anazi.2017.1419">Anazi et al [2017]</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.chelban.2017.969">Chelban et al [2017]</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.dorboz.2017.2550">Dorboz et al [2017]</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.baldi.2018.1087">Baldi et al [2018]</a></p></div></dd><dt>5. </dt><dd><div id="nkx6-2-spax.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div></div><div id="nkx6-2-spax.Clinical_Characteristics"><h2 id="_nkx6-2-spax_Clinical_Characteristics_">Clinical Characteristics</h2><div id="nkx6-2-spax.Clinical_Description"><h3>Clinical Description</h3><p><i>NKX6-2</i>-related disorder is characterized by a spectrum of progressive neurologic manifestations resulting from diffuse central nervous system hypomyelination. To date <i>NKX6-2</i>-related disorder has been reported in 25 individuals from 13 families [<a class="bk_pop" href="#nkx6-2-spax.REF.anazi.2017.1419">Anazi et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.chelban.2017.969">Chelban et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.dorboz.2017.2550">Dorboz et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.baldi.2018.1087">Baldi et al 2018</a>].</p><p>At the severe end of the spectrum is neonatal-onset nystagmus, severe spastic tetraplegia with joint contractures and scoliosis, and visual and hearing impairment, all of which rapidly progress resulting in death in early childhood. At the milder end of the spectrum is normal achievement of motor milestones in the first year of life followed by slowly progressive complex spastic ataxia with pyramidal findings (spasticity with increased muscle tone and difficulty with gait and fine motor coordination), cerebellar findings (nystagmus, extraocular movement disorder, dysarthria, titubation, and ataxia), and loss of developmental milestones.</p><p>Affected individuals are born at term following uneventful pregnancy and delivery.</p><p>Nystagmus is usually the first manifestation and has been reported as early as age three months. Other ocular features include loss of visual fixation and ocular pursuit, reduced up-gaze, and limited voluntary eye movements [<a class="bk_pop" href="#nkx6-2-spax.REF.chelban.2017.969">Chelban et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.dorboz.2017.2550">Dorboz et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.baldi.2018.1087">Baldi et al 2018</a>].</p><p>Pyramidal syndrome, characterized by increased muscle tone in the lower extremities, hyperreflexia, and positive Babinski sign, has been present in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date. Some children with neonatal onset presented with hypotonia that progressed to spasticity within a few months [<a class="bk_pop" href="#nkx6-2-spax.REF.dorboz.2017.2550">Dorboz et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.baldi.2018.1087">Baldi et al 2018</a>].</p><p>Extrapyramidal syndrome can be associated with <i>NKX6-2</i>-related disorders and most frequently presents with cervical and/or limb dystonia that can lead to development of joint contractures.</p><p>Cerebellar syndrome develops during later infancy and is characterized by dysarthria, titubation, and truncal and limb ataxia. Complications such as dysphagia lead to recurrent aspirations and the need for gastrostomy feedings in more advanced stages [<a class="bk_pop" href="#nkx6-2-spax.REF.dorboz.2017.2550">Dorboz et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.baldi.2018.1087">Baldi et al 2018</a>]. Not all children develop a cerebellar syndrome.</p><p>Walking and mobility vary. Children with neonatal onset and severe disease never achieve ambulation [<a class="bk_pop" href="#nkx6-2-spax.REF.dorboz.2017.2550">Dorboz et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.baldi.2018.1087">Baldi et al 2018</a>]. At the milder end of the spectrum <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals achieve early motor milestones (sitting independently) but are not able to walk well or run. Mobility aids are used during childhood, and disease progression typically leads to wheelchair dependence in the second decade of life [<a class="bk_pop" href="#nkx6-2-spax.REF.chelban.2017.969">Chelban et al 2017</a>].</p><p>Cognitive function varies greatly. Severe developmental language and motor delay with arrested speech development was reported in children at the severe end of the spectrum [<a class="bk_pop" href="#nkx6-2-spax.REF.anazi.2017.1419">Anazi et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.dorboz.2017.2550">Dorboz et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.baldi.2018.1087">Baldi et al 2018</a>]. In contrast, some individuals have mild intellectual disability, and one individual has normal cognitive function and has completed a university degree [<a class="bk_pop" href="#nkx6-2-spax.REF.chelban.2017.969">Chelban et al 2017</a>]. However, in some instances cognitive function is difficult to assess fully due to severe motor impairment.</p><p>Seizures have been reported in some individuals. The motor <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> can vary from severe [<a class="bk_pop" href="#nkx6-2-spax.REF.anazi.2017.1419">Anazi et al 2017</a>] to mild. Clinically evident tonic seizures, secondary generalized seizures, and focal seizures have been confirmed on electroencephalography [Author, personal observation].</p><p>The following additional features have been reported:</p><ul><li class="half_rhythm"><div>Failure to achieve head control</div></li><li class="half_rhythm"><div>Hearing impairment</div></li><li class="half_rhythm"><div>Recurrent apnea, with some children developing respiratory failure that leads to early death</div></li><li class="half_rhythm"><div>Congenital abnormalities including <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease and undescended testes</div></li></ul><p><b>Neurophysiologic studies</b></p><ul><li class="half_rhythm"><div>Normal electromyogram and nerve conduction studies [<a class="bk_pop" href="#nkx6-2-spax.REF.chelban.2017.969">Chelban et al 2017</a>]</div><ul class="simple-list"><li class="half_rhythm"><div>Delayed visual evoked potentials [<a class="bk_pop" href="#nkx6-2-spax.REF.dorboz.2017.2550">Dorboz et al 2017</a>]</div></li></ul></li><li class="half_rhythm"><div>Absent somatosensory evoked potentials</div></li><li class="half_rhythm"><div>On EEG, loss of age-based background activity and absent anterior-posterior gradient of background activity and multifocal epileptic discharges [Author, personal observation]</div></li></ul></div><div id="nkx6-2-spax.GenotypePhenotype_Correlatio"><h3>Genotype-Phenotype Correlations</h3><p>No clear <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>NKX6-2</i> pathogenic variants.</p><p>Of note, <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in the homeobox <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (<a class="figpopup" href="/books/NBK531509/table/nkx6-2-spax.T.nkx62_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="fignkx62spaxTnkx62pathogenicvariants" rid-ob="figobnkx62spaxTnkx62pathogenicvariants">c.487C&#x0003e;G</a>, <a class="figpopup" href="/books/NBK531509/table/nkx6-2-spax.T.nkx62_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="fignkx62spaxTnkx62pathogenicvariants" rid-ob="figobnkx62spaxTnkx62pathogenicvariants">c.606delinsTA</a>, <a class="figpopup" href="/books/NBK531509/table/nkx6-2-spax.T.nkx62_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="fignkx62spaxTnkx62pathogenicvariants" rid-ob="figobnkx62spaxTnkx62pathogenicvariants">c.565G&#x0003e;T</a>, <a class="figpopup" href="/books/NBK531509/table/nkx6-2-spax.T.nkx62_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="fignkx62spaxTnkx62pathogenicvariants" rid-ob="figobnkx62spaxTnkx62pathogenicvariants">c.599G&#x0003e;A</a>, <a class="figpopup" href="/books/NBK531509/table/nkx6-2-spax.T.nkx62_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="fignkx62spaxTnkx62pathogenicvariants" rid-ob="figobnkx62spaxTnkx62pathogenicvariants">c.589C&#x0003e;T</a>, <a class="figpopup" href="/books/NBK531509/table/nkx6-2-spax.T.nkx62_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="fignkx62spaxTnkx62pathogenicvariants" rid-ob="figobnkx62spaxTnkx62pathogenicvariants">c.608G&#x0003e;A</a>, <a class="figpopup" href="/books/NBK531509/table/nkx6-2-spax.T.nkx62_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="fignkx62spaxTnkx62pathogenicvariants" rid-ob="figobnkx62spaxTnkx62pathogenicvariants">c.196delC</a>) are associated with a severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> including early onset (i.e., soon after birth), severe psychomotor developmental delay, widespread hypomyelination on MRI, and rapid disease progression leading in some instances to death in the first years of life [<a class="bk_pop" href="#nkx6-2-spax.REF.anazi.2017.1419">Anazi et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.chelban.2017.969">Chelban et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.dorboz.2017.2550">Dorboz et al 2017</a>, <a class="bk_pop" href="#nkx6-2-spax.REF.baldi.2018.1087">Baldi et al 2018</a>].</p></div><div id="nkx6-2-spax.Prevalence"><h3>Prevalence</h3><p>Prevalence is not known. To date, 25 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from 13 families of different ethnic backgrounds (northern European, Arab, North African, Asian) have been reported.</p></div></div><div id="nkx6-2-spax.Genetically_Related_Allelic"><h2 id="_nkx6-2-spax_Genetically_Related_Allelic_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>NKX6</i>-<i>2</i>.</p></div><div id="nkx6-2-spax.Differential_Diagnosis"><h2 id="_nkx6-2-spax_Differential_Diagnosis_">Differential Diagnosis</h2><p>Hypomyelinating leukodystrophies and spastic ataxias (particularly when associated with hypomyelination) should be considered in the differential diagnosis of <i>NKX6-2</i> related disorder. See <a class="figpopup" href="/books/NBK531509/table/nkx6-2-spax.T.movement_disorders_to_cons/?report=objectonly" target="object" rid-figpopup="fignkx62spaxTmovementdisorderstocons" rid-ob="figobnkx62spaxTmovementdisorderstocons">Table 2</a>.</p><div id="nkx6-2-spax.T.movement_disorders_to_cons" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Movement Disorders to Consider in the Differential Diagnosis of <i>NKX6</i>-<i>2</i>-Related Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK531509/table/nkx6-2-spax.T.movement_disorders_to_cons/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nkx6-2-spax.T.movement_disorders_to_cons_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4" colspan="4" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Overlapping Clinical Features</th><th id="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing Clinical Features</th></tr><tr><th headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_3" id="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"></th><th headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4" id="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Onset</th><th headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4" id="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Movement disorder</th><th headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4" id="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brain MRI</th><th headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4" id="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other</th><th headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_5" id="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th></tr></thead><tbody><tr><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pelizaeus-Merzbacher disease (PMD) (see <a href="/books/n/gene/pmd/">PLP-Related Disorders</a>)</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLP1</i></td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_3 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infancy or early childhood</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pyramidal, extrapyramidal, &#x00026; cerebellar</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Diffuse hypomyelination; cerebellar atrophy</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early-onset nystagmus</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_5 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Null <i>PLP1</i> variants are associated w/mild demyelinating neuropathy &#x00026; reduced levels of N-acetyl aspartate in cerebral white matter.</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pmld1/">Pelizaeus-Merzbacher-like disease 1</a> (PMLD1)</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GJC2</i></td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_3 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early childhood</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pyramidal, extrapyramidal, &#x00026; cerebellar</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Diffuse hypomyelination</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Very similar to <i>NKX6-2</i>-related disorder</div></li><li class="half_rhythm"><div>Developmental &#x00026; speech delay</div></li><li class="half_rhythm"><div>Preservation of cognition</div></li></ul></td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_5 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In PMLD1:
<ul><li class="half_rhythm"><div>Thinning of the corpus callosum in some</div></li><li class="half_rhythm"><div>No cerebellar atrophy on MRI</div></li></ul></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pol3-leuk/">POLR3-related leukodystrophy</a></td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLR3A</i><br /><i>POLR3B</i><br /><i>POLR1C</i></td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_3 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early childhood</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pyramidal, extrapyramidal, &#x00026; cerebellar</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Diffuse hypomyelination</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_5 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">InPOLR3-related leukodystrophy:
<ul><li class="half_rhythm"><div>Abnormal dentition</div></li><li class="half_rhythm"><div>Hypogonadotropic hypogonadism</div></li></ul></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypomyelination w/atrophy of basal ganglia &#x00026; cerebellum (H-ABC) (see <a href="/books/n/gene/tubb4a-leuk/"><i>TUBB4A</i>-Related Leukodystrophy</a>)</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBB4A</i></td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_3 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infancy or childhood</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pyramidal &#x00026; cerebellar</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Diffuse cerebral hypomyelination</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Motor developmental delay</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_5 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In H-ABC:
<ul><li class="half_rhythm"><div>Abnormalities of basal ganglia, particularly atrophy (a classic sign)</div></li><li class="half_rhythm"><div>Aphonia or "whispering" dysphonia may be a feature.&#x000a0;<sup>1</sup></div></li></ul></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Salla disease (see <a href="/books/n/gene/issd/">Free Sialic Acid Storage Disorders</a>)</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC17A5</i></td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_3 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Birth</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pyramidal &#x00026; extrapyramidal</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypomyelination</td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_4 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Psychomotor retardation</div></li><li class="half_rhythm"><div>Seizures</div></li></ul></td><td headers="hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_1_5 hd_h_nkx6-2-spax.T.movement_disorders_to_cons_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In severe form of Salla disease:
<ul><li class="half_rhythm"><div>Severe developmental delay</div></li><li class="half_rhythm"><div>Coarse facial features</div></li><li class="half_rhythm"><div>Hepatosplenomegaly</div></li><li class="half_rhythm"><div>Cardiomegaly</div></li><li class="half_rhythm"><div>Death usually in early childhood</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a></p></div></dd><dt></dt><dd><div><p class="no_margin">XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="nkx6-2-spax.TF.2.1"><p class="no_margin"><i>TUBB4A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.4C&#x0003e;G causes the adult-onset disorder laryngeal dysphonia or whispering dysphonia (also known as DYT4 dystonia), with normal MRI.</p></div></dd></dl></div></div></div><p>See <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>, <a href="/books/n/gene/hsp/">Hereditary Spastic Paraplegia Overview</a>, and <a href="/books/n/gene/leukodys-ov/">Leukodystrophy Overview</a>.</p><p>See <a href="http://www.omim.org/phenotypicSeries/PS108600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Spastic Ataxia: OMIM Phenotypic Series</a> and <a href="http://omim.org/phenotypicSeries/PS312080" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hypomyelinating Leukodystrophy: OMIM Phenotypic Series</a> to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div><div id="nkx6-2-spax.Management"><h2 id="_nkx6-2-spax_Management_">Management</h2><div id="nkx6-2-spax.Evaluations_Following_Initia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>NKX6</i>-<i>2</i>-related disorder, the evaluations summarized in <a class="figpopup" href="/books/NBK531509/table/nkx6-2-spax.T.recommended_evaluations_fo/?report=objectonly" target="object" rid-figpopup="fignkx62spaxTrecommendedevaluationsfo" rid-ob="figobnkx62spaxTrecommendedevaluationsfo">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="nkx6-2-spax.T.recommended_evaluations_fo" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis of <i>NKX6</i>-<i>2</i>-Related Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK531509/table/nkx6-2-spax.T.recommended_evaluations_fo/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nkx6-2-spax.T.recommended_evaluations_fo_lrgtbl__"><table><thead><tr><th id="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constitutional</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Height, weight, head circumference</td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for evidence of failure to thrive.</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for:
<ul><li class="half_rhythm"><div>Reduced vision;</div></li><li class="half_rhythm"><div>Abnormal ocular movement.</div></li></ul></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiologic evaluation</td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for hearing loss.</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consideration of echocardiogram</td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To screen for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of :
<ul><li class="half_rhythm"><div>Airway</div></li><li class="half_rhythm"><div>Pulmonary function</div></li><li class="half_rhythm"><div>Secretion management</div></li></ul></td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sleep study to assess for apnea</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment (particularly in later stages of disease) of:
<ul><li class="half_rhythm"><div>Swallowing</div></li><li class="half_rhythm"><div>Feeding</div></li><li class="half_rhythm"><div>Nutritional status</div></li></ul></td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Determine safety of oral vs gastrostomy feeding.</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to specialist in pediatric pain management</td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For those who have pain due to deforming joint contractures</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Referral to rehabilitation specialist</td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate mobility &#x00026; ability to perform activities of daily living</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physical examination for cryptorchidism in males</td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer males w/cryptorchidism to urologist.</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to pediatric neurologist</td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for evidence of spasticity &#x00026;/or seizure activity.</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist or genetic counselor</td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate the following:
<ul><li class="half_rhythm"><div>Motor skills</div></li><li class="half_rhythm"><div>Speech/language</div></li><li class="half_rhythm"><div>General cognitive skills</div></li><li class="half_rhythm"><div>Vocational skills</div></li></ul></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Referral to palliative care specialist</td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">When deemed appropriate by family &#x00026; care providers</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Family support/resources</td><td headers="hd_h_nkx6-2-spax.T.recommended_evaluations_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Community or online resources (e.g., Parent to Parent)</div></li><li class="half_rhythm"><div>Social work involvement for parental support</div></li><li class="half_rhythm"><div>Home nursing referral if needed</div></li></ul></td></tr></tbody></table></div></div></div><div id="nkx6-2-spax.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="nkx6-2-spax.T.treatment_of_manifestation" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with <i>NKX6</i>-<i>2</i>-Related Spastic Ataxia with Hypomyelination</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK531509/table/nkx6-2-spax.T.treatment_of_manifestation/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nkx6-2-spax.T.treatment_of_manifestation_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/<br />Concern</th><th id="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment as per ophthalmology review</td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Community vision services through early intervention or school district</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b></td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hearing aids may be helpful as per otolaryngologist.</td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Community hearing services through early intervention or school district</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Congenital heart defect</b></td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per cardiologist</td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory insufficiency</b></td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment as per respiratory review; consider assisted ventilation as appropriate.</td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Airway &#x00026; pulmonary assessment for evidence of decreased pulmonary function or poor secretion management</div></li><li class="half_rhythm"><div>Sleep study</div></li></ul></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dysphagia/</b><br /><b>Inadequate</b><br /><b>nutrition</b></td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nasogastric or gastrostomy tube may be required.</td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Maintain a low threshold for clinical feeding evaluation &#x00026;/or radiographic swallowing study when patient shows clinical signs &#x00026;/or symptoms of dysphagia.</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cryptorchidism</b></td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per urologist</td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Spasticity</b></td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Physiotherapy (incl stretching) to avoid contractures &#x00026; falls</div></li><li class="half_rhythm"><div>Trial of pharmaceutical agents (e.g., baclofen or tizanidine) as recommended by rehabilitation specialist</div></li></ul></td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Assess for evidence of spasticity.</div></li><li class="half_rhythm"><div>Consider need for positioning &#x00026; mobility devices, disability parking placard.</div></li></ul></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizures</b></td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Antiepileptic drugs</td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically difficult to control&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Family/</b><br /><b>Community</b></td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Appropriate social work involvement to connect families w/local resources, respite, &#x00026; support</div></li><li class="half_rhythm"><div>Care coordination to manage multiple subspecialty appointments, equipment, medications, &#x00026; supplies</div></li></ul></td><td headers="hd_h_nkx6-2-spax.T.treatment_of_manifestation_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ongoing assessment for need of palliative care involvement &#x00026;/or home nursing</div></li><li class="half_rhythm"><div>Consider involvement in adaptive sports or Special Olympics</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="nkx6-2-spax.TF.4.1"><p class="no_margin">Education of parents regarding common seizure presentations is appropriate. For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <a href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child Toolkit</a>.</p></div></dd></dl></div></div></div><div id="nkx6-2-spax.Developmental_Disability__In"><h4>Developmental Disability / Intellectual Disability Management Issues</h4><p>Note: The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy as well as infant mental health services, special educators, and sensory impairment specialists. In the US, early intervention is a federally funded program available in all states; it provides in-home services to target individual therapy needs.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed for those who qualify based on established motor, language, social, or cognitive delay. The early intervention program typically assists with this transition. Developmental preschool is center based; however, home-based services are provided for children too medically unstable to attend.</p><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life. Some issues to consider:</p><ul><li class="half_rhythm"><div><b>IEP services</b> are for those who require specially designed instruction / related services.</div><ul><li class="half_rhythm"><div>IEP services will be reviewed annually to determine if any changes are needed.</div></li><li class="half_rhythm"><div>As required by special education law, children should be in the least restricted environment at school and included in general education as much as possible and when appropriate.</div></li><li class="half_rhythm"><div>Vision and hearing consultants should be a part of the child's IEP team to support access to academic material.</div></li><li class="half_rhythm"><div>PT, OT, and speech services will be provided in the IEP to the extent that the need affects the child's access to academic material. Beyond that, private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs may be considered. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</div></li><li class="half_rhythm"><div>As a child enters teen years, a transition plan should be discussed and incorporated in the IEP. For those receiving IEP services, the public school district is required to provide services until age 21 years.</div></li></ul></li><li class="half_rhythm"><div><b>504 plan services</b> can be considered for those who require accommodations or modifications including front-of-class seating, assistive technology devices, classroom scribes, extra time between classes, modified assignments, enlarged text,and other accomodations.</div></li><li class="half_rhythm"><div><b>Developmental Disabilities Administration</b> (DDA) enrollment is recommended. DDA is a public agency in the US that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="nkx6-2-spax.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility and to reduce the risk for later-onset orthopedic complications (e.g., contractures, scoliosis, hip dislocation).</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment and positioning devices as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li><li class="half_rhythm"><div>For muscle tone abnormalities including hypertonia or dystonia, consider involving appropriate specialists to aid in management of baclofen, tizanidine, Botox<sup>&#x000ae;</sup>, anti-parkinsonian medications, or orthopedic procedures.</div></li></ul><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties. An AAC evaluation can be completed by a speech language pathologist who has expertise in the area. The evaluation will consider cognitive abilities and sensory impairments to determine the most appropriate form of communication. AAC devices can range from low-tech, such as picture exchange communication, to high-tech, such as voice-generating devices. Contrary to popular belief, AAC devices do not hinder verbal development of speech and, in many cases, can improve it.</p><p><b>Oral motor dysfunction</b> should be assessed at each visit and clinical feeding evaluations and/or radiographic swallowing studies should be obtained for choking/gagging during feeds, poor weight gain, frequent respiratory illnesses or feeding refusal that is not otherwise explained. Assuming that the child is safe to eat by mouth, feeding therapy (typically from an occupational or speech therapist) is recommended to help improve coordination or sensory-related feeding issues. Feeds can be thickened or chilled for safety. When feeding dysfunction is severe, an NG-tube or G-tube may be necessary.</p></div></div><div id="nkx6-2-spax.Prevention_of_Secondary_Comp"><h3>Prevention of Secondary Complications</h3><p>The following additional recommendations are based on the leukodystrophies consensus [<a class="bk_pop" href="#nkx6-2-spax.REF.van_haren.2015.516">Van Haren et al 2015</a>]:</p><ul><li class="half_rhythm"><div>Frequent repositioning and skin care to avoid skin sores in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who are not mobile</div></li><li class="half_rhythm"><div>Yearly flu vaccination</div></li><li class="half_rhythm"><div>Vitamin D supplementation (to prevent osteoporosis)</div></li></ul></div><div id="nkx6-2-spax.Surveillance"><h3>Surveillance</h3><div id="nkx6-2-spax.T.recommended_surveillance_f" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with <i>NKX6</i>-<i>2</i>-Related Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK531509/table/nkx6-2-spax.T.recommended_surveillance_f/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nkx6-2-spax.T.recommended_surveillance_f_lrgtbl__"><table><thead><tr><th id="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Visual acuity &#x00026; eye movement</td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Formal audiology assessment</td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As required</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sleep studies recommended if signs of apnea</td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As required</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal/</b><br /><b>Feeding</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Measurement of growth parameters</td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Evaluation of nutritional status &#x00026; safety of oral intake</td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of developmental progress</td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Assessment for progression of spasticity &#x00026; contractures w/yearly hip &#x00026; spine x-ray</td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">EEG</td><td headers="hd_h_nkx6-2-spax.T.recommended_surveillance_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If concerns for new seizure activity or progression of seizures</td></tr></tbody></table></div></div></div><div id="nkx6-2-spax.Evaluation_of_Relatives_at_R"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#nkx6-2-spax.Related_Genetic_Counseling_I">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="nkx6-2-spax.Therapies_Under_Investigatio"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="nkx6-2-spax.Genetic_Counseling"><h2 id="_nkx6-2-spax_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="nkx6-2-spax.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>NKX6</i>-<i>2</i>-related disorder is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>NKX6</i>-<i>2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> To date, individuals with <i>NKX6</i>-<i>2</i>-related disorder are not known to reproduce.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>NKX6</i>-<i>2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="nkx6-2-spax.Carrier_Heterozygote_Detecti"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>NKX6</i>-<i>2</i> pathogenic variants in the family.</p></div><div id="nkx6-2-spax.Related_Genetic_Counseling_I"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="nkx6-2-spax.Prenatal_Testing_and_Preimpl"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>NKX6</i>-<i>2</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="nkx6-2-spax.Resources"><h2 id="_nkx6-2-spax_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Hereditary-Spastic-Paraplegia-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Spastic Paraplegia Information Page</a></div></li><li class="half_rhythm"><div><b>Spastic Paraplegia Foundation, Inc.</b></div><div>7700 Leesburg Pike</div><div>Ste 123</div><div>Falls Church VA 22043</div><div><b>Phone:</b> 877-773-4483 (toll-free)</div><div><b>Email:</b> information@sp-foundation.org</div><div><a href="http://sp-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">sp-foundation.org</a></div></li><li class="half_rhythm"><div><b>Ataxia UK</b></div><div>Lincoln House</div><div>1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> 0845 644 0606 (helpline); 020 7582 1444 (office); +44 (0) 20 7582 1444 (from abroad)</div><div><b>Email:</b> helpline@ataxia.org.uk; office@ataxia.org.uk</div><div><a href="http://www.ataxia.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org.uk</a></div></li><li class="half_rhythm"><div><b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b></div><div>Ataxia UK</div><div>Lincoln House, Kennington Park, 1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 207 582 1444</div><div><b>Email:</b> smillman@ataxia.org.uk</div><div><a href="https://www.euroataxia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euroataxia.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li></ul></div><div id="nkx6-2-spax.Molecular_Genetics"><h2 id="_nkx6-2-spax_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="nkx6-2-spax.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>NKX6-2-Related Disorder: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK531509/table/nkx6-2-spax.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nkx6-2-spax.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_nkx6-2-spax.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_nkx6-2-spax.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_nkx6-2-spax.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_nkx6-2-spax.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_nkx6-2-spax.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_nkx6-2-spax.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/84504" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>NKX6-2</i></a></td><td headers="hd_b_nkx6-2-spax.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=84504" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q26<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_nkx6-2-spax.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9C056" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Homeobox protein Nkx-6.2</a></td><td headers="hd_b_nkx6-2-spax.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=NKX6-2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NKX6-2</a></td><td headers="hd_b_nkx6-2-spax.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NKX6-2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NKX6-2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="nkx6-2-spax.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="nkx6-2-spax.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for NKX6-2-Related Disorder (<a href="/omim/605955,617560" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK531509/table/nkx6-2-spax.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nkx6-2-spax.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605955" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605955</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NK6, DROSOPHILA, HOMOLOG OF, 2; NKX6-2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/617560" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">617560</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>NKX6-2</i> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_177400.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_177400.2</a>) has three exons and encodes a protein of 277 amino acids (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_796374.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_796374.1</a>).</p><p><b>Pathogenic variants.</b> Known pathogenic variants are listed in <a class="figpopup" href="/books/NBK531509/table/nkx6-2-spax.T.nkx62_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="fignkx62spaxTnkx62pathogenicvariants" rid-ob="figobnkx62spaxTnkx62pathogenicvariants">Table 6</a>.</p><div id="nkx6-2-spax.T.nkx62_pathogenic_variants" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p><i>NKX6</i>-<i>2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK531509/table/nkx6-2-spax.T.nkx62_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nkx6-2-spax.T.nkx62_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.121A&#x0003e;T</td><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys41Ter</td><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_3" rowspan="8" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_177400.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_177400<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_796374.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_796374<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.196delC</td><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg66GlyfsTer122</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.487C&#x0003e;G</td><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu163Val</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.565G&#x0003e;T</td><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu189Ter</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.589C&#x0003e;T</td><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln197Ter</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.599G&#x0003e;A</td><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg200Gln</td></tr><tr><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.606delinsTA</td><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys202Asnfs?&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.608G&#x0003e;A</td><td headers="hd_h_nkx6-2-spax.T.nkx62_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp203Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="nkx6-2-spax.TF.6.1"><p class="no_margin">? = The predicted consequence of a frame-shifting variant changes Lys202 to Asn, but the new reading frame does not encounter a new translation termination (stop) codon.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>NKX6-2</i> is a recently identified member of the human homeobox gene family, which has more than 330 loci comprising 255 genes and 78 likely pseudogenes [<a class="bk_pop" href="#nkx6-2-spax.REF.zhong.2011.169">Zhong &#x00026; Holland 2011</a>]. All homeobox family members share a sequence of 180 base pairs encoding a string of 60 self-folding amino acids [<a class="bk_pop" href="#nkx6-2-spax.REF.gehring.1993.215">Gehring 1993</a>] recognized as the homeodomain that acts as a <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a>. NKX6-2 comprises 277 amino acids and has one functional <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> &#x02013; the homeobox (residues 151-204 of <a href="https://www.ncbi.nlm.nih.gov/protein/NP_796374.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_796374.1</a>).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Truncating variants can be located throughout <i>NKX6-2</i> and lead to disease through a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> mechanism. All reported pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants affect the major functional <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of NKX6-2, the homeobox. It is likely that disruption of the highly conserved homeobox sequence also disrupts DNA binding.</p></div><div id="nkx6-2-spax.References"><h2 id="_nkx6-2-spax_References_">References</h2><div id="nkx6-2-spax.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="nkx6-2-spax.REF.anazi.2017.1419">Anazi S, Maddirevula S, Salpietro V, Asi YT, Alsahli S, Alhashem A, Shamseldin HE, AlZahrani F, Patel N, Ibrahim N, Abdulwahab FM, Hashem M, Alhashmi N, Al Murshedi F, Al Kindy A, Alshaer A, Rumayyan A, Al Tala S, Kurdi W, Alsaman A, Alasmari A, Banu S, Sultan T, Saleh MM, Alkuraya H, Salih MA, Aldhalaan H, Ben-Omran T, Al Musafri F, Ali R, Suleiman J, Tabarki B, El-Hattab AW, Bupp C, Alfadhel M, Al Tassan N, Monies D, Arold ST, Abouelhoda M, Lashley T, Houlden H, Faqeih E, Alkuraya FS. Expanding the genetic heterogeneity of intellectual disability. <span><span class="ref-journal">Hum Genet. </span>2017;<span class="ref-vol">136</span>:1419–29.</span> [<a href="/pubmed/28940097" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28940097</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nkx6-2-spax.REF.baldi.2018.1087">Baldi C, Bertoli-Avella AM, Al-Sannaa N, Alfadhel M, Al-Thihli K, Alameer S, Elmonairy AA, Al Shamsi AM, Abdelrahman HA, Al-Gazali L, Shawli A, Al-Hakami F, Yavuz H, Kandaswamy KK, Rolfs A, Brandau O, Bauer P. Expanding the clinical and genetic spectra of NKX6-2-related disorder. <span><span class="ref-journal">Clin Genet. </span>2018;<span class="ref-vol">93</span>:1087–92.</span> [<a href="/pubmed/29388673" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29388673</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nkx6-2-spax.REF.chelban.2017.969">Chelban V, Patel N, Vandrovcova J, Zanetti MN, Lynch DS, Ryten M, Bot&#x000ed;a JA, Bello O, Tribollet E, Efthymiou S, Davagnanam I, Bashiri FA, Wood NW, Rothman JE, Alkuraya FS, Houlden H, et al.  Mutations in NKX6-2 cause progressive spastic ataxia and hypomyelination. <span><span class="ref-journal">Am J Hum Genet. </span>2017;<span class="ref-vol">100</span>:969–77.</span> [<a href="/pmc/articles/PMC5473715/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5473715</span></a>] [<a href="/pubmed/28575651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28575651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nkx6-2-spax.REF.dorboz.2017.2550">Dorboz I, Aiello C, Simons C, Stone RT, Niceta M, Elmaleh M, Abuawad M, Doummar D, Bruselles A, Wolf NI, Travaglini L, Boespflug-Tanguy O, Tartaglia M, Vanderver A, Rodriguez D, Bertini E. Biallelic mutations in the homeodomain of NKX6-2 underlie a severe hypomyelinating leukodystrophy. <span><span class="ref-journal">Brain. </span>2017;<span class="ref-vol">140</span>:2550–6.</span> [<a href="/pubmed/28969374" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28969374</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nkx6-2-spax.REF.gehring.1993.215">Gehring WJ. Exploring the homeobox. <span><span class="ref-journal">Gene. </span>1993;<span class="ref-vol">135</span>:215–21.</span> [<a href="/pubmed/7903947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7903947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nkx6-2-spax.REF.van_haren.2015.516">Van Haren K, Bonkowsky JL, Bernard G, Murphy JL, Pizzino A, Helman G, Suhr D, Waggoner J, Hobson D, Vanderver A, Patterson MC, et al.  Consensus statement on preventive and symptomatic care of leukodystrophy patients. <span><span class="ref-journal">Mol Genet Metab. </span>2015;<span class="ref-vol">114</span>:516–26.</span> [<a href="/pubmed/25577286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25577286</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nkx6-2-spax.REF.zhong.2011.169">Zhong YF, Holland PW. The dynamics of vertebrate homeobox gene evolution: gain and loss of genes in mouse and human lineages. <span><span class="ref-journal">BMC Evol Biol. </span>2011;<span class="ref-vol">11</span>:169.</span> [<a href="/pmc/articles/PMC3141429/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3141429</span></a>] [<a href="/pubmed/21679462" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21679462</span></a>]</div></li></ul></div></div><div id="nkx6-2-spax.Chapter_Notes"><h2 id="_nkx6-2-spax_Chapter_Notes_">Chapter Notes</h2><div id="nkx6-2-spax.Author_Notes"><h3>Author Notes</h3><p><b>King Abdulaziz City for Science and Technology</b><br />Riyadh 12371, Saudi Arabia<br />Phone: +966 11 488 3555<br />Email: <a href="mailto:dev@null" data-email="as.ude.tscak@aidem" class="oemail">as.ude.tscak@aidem</a><br /><a href="https://www.kacst.edu.sa/eng/Pages/default.aspx" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Website</a></p><p><b>Saudi Human Genome Program</b><br /><a href="http://shgp.kacst.edu.sa/site/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Website</a></p><p><b>King Salman Center for Disability Research</b><br />PO Box 94682<br />Riyadh 11614, Saudi Arabia<br />Phone:+966 11 4884401<br /><a href="http://www.kscdr.org.sa/en" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Website</a></p></div><div id="nkx6-2-spax.Acknowledgments"><h3>Acknowledgments</h3><p>The authors would like to thank the patients and their families for their essential help with this work. We are grateful to the Spastic Paraplegia Foundation and the UK HSP Society, the Medical Research Council (MRC UK MR/J004758/1, G0802760, G1001253), the Wellcome Trust (WT093205MA and WT104033/Z/14/Z), the Brain Research Trust (BRT), the MSA Trust, the European Union Seventh Framework Programme FP7 (NeurOmics), Ataxia UK, the British Neurological Surveillance Unit (BNSU), the National Institute for Health Research (NIHR) University College London Hospitals (UCLH), the Biomedical Research Centre (BRC), King Abdulaziz City for Science and Technology (KACST # 14-MED2007-20), and King Salman Center for Disability Research (KSCDR # 2180 004).</p></div><div id="nkx6-2-spax.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>4 October 2018 (bp) Review posted live</div></li><li class="half_rhythm"><div>7 February 2018 (vc) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK531509</span><span class="label">PMID: <a href="/pubmed/30285346" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">30285346</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/nkx2-1-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ahc/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK531509&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK531509/?report=reader">PubReader</a></li><li><a href="/books/NBK531509/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK531509" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK531509" style="display:none" title="Cite this Page"><div class="bk_tt">Chelban V, Kaya N, Alkuraya F, et al. NKX6-2-Related Disorder. 2018 Oct 4. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK531509/pdf/Bookshelf_NBK531509.pdf">PDF version of this page</a> (797K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#nkx6-2-spax.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#nkx6-2-spax.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#nkx6-2-spax.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#nkx6-2-spax.Genetically_Related_Allelic" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#nkx6-2-spax.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#nkx6-2-spax.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#nkx6-2-spax.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#nkx6-2-spax.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#nkx6-2-spax.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#nkx6-2-spax.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#nkx6-2-spax.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84504[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NKX6-2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4626376" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4626376" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4626376" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4626376" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31509304" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Genetic and phenotypic characterization of NKX6-2-related spastic ataxia and hypomyelination.</a><span class="source">[Eur J Neurol. 2019]</span><div class="brieflinkpop offscreen_noflow">Genetic and phenotypic characterization of NKX6-2-related spastic ataxia and hypomyelination.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chelban V, Alsagob M, Kloth K, Chirita-Emandi A, Vandrovcova J, Maroofian R, Davagnanam I, Bakhtiari S, AlSayed MD, Rahbeeni Z, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Neurol. 2019 Sep 11; . Epub 2019 Sep 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29276893" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pelizaeus-Merzbacher-Like Disease 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pelizaeus-Merzbacher-Like Disease 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nahhas N, Conant A, Orthmann-Murphy J, Vanderver A, Hobson G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30869852" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> FARS2 Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> FARS2 Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Almannai M, Faqeih E, El-Hattab AW, Wong LJC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301553" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> SYNE1 Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> SYNE1 Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Beaudin M, Gamache PL, Gros-Louis F, Dupré N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301286" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 7</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 7<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Casari G, Marconi R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=30285346" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=30285346" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0414bf75f66d18aa226af9">NKX6-2-Related Disorder - GeneReviews®</a><div class="ralinkpop offscreen_noflow">NKX6-2-Related Disorder - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:02:40-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D3324E040F36100000000026100DD&amp;ncbi_session=CE8D3324E0414BF1_0609SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK531509%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK531509&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK531509/&amp;ncbi_pagename=NKX6-2-Related Disorder - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D3324E0414BF1_0609SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>